You are here: Industry Insights > NMPA

News List

Pharma Co-packaging Regulations Muhammad Asim Niazi
March 21, 2023
Let’s discuss some regulatory requirements for contract packaging in line with three most competitive markets i.e China , United States and Europe.
Monthly Pharma News Review of PharmaSources (February) - Chinese Drug review and approval Caicai/PharmaSources
March 14, 2023
The anti-PD-L1 monoclonal antibody Adebrelimab from Hengrui Pharmaceuticals was approved for marketing, and the Class 3 chemotherapy Limaprost tablets from Sino Biopharm were approved for marketing.
Drug Marketing in China and Worldwide (July) Caicai/PharmaSources
August 11, 2023
On July 6th, Eisai's lecanemab (Leqembi) was fully approved by the FDA for the treatment of Alzheimer's disease
Drug Marketing in China and Worldwide (April) PharmaSources
May 12, 2023
Summary of Drug Marketing at Home and Abroad (April)
Weekly Pharma News Review | PharmaSources.com (0808-0812) PharmaSources.com
August 17, 2022
The FDA approved the supplementary new drug application for Bayer’s darolutamide in combination with docetaxel, which sparked widespread social attention. The news review of this week is from August 8 to 12, covering a total of 23 pieces of information.
Weekly Pharma News Review | PharmaSources.com (May. 23th - May. 29th) PharmaSources.com
May 31, 2022
This week, a steady flow of good news kept pouring into the Chinese pharmaceutical market. The local "first-in-class" Benvimod was successfully approved by FDA while Hengrui's SHR3680 tablets in treating prostate cancer had a successful Phase III clinical
Drug Marketing in China and Worldwide (March) PharmaSources
May 10, 2023
Summary of drug marketing at home and abroad (March)
Weekly Pharma News Review | PharmaSources.com （April.18th - 22ed） PharmaSources.com
April 27, 2022
The pharma news review of this week totally covers 22 pieces of news in 3 sections, including drug review, R&D, and business.
Bivalent HPV Vaccine of Walvax Approved for Marketing: Who Will be the Leader of the Market Valuing RMB 100 billion? Yefenghong
April 11, 2022
Bivalent HPV Vaccine of Walvax Approved for Marketing: Who Will be the Leader of the Market Valuing RMB 100 billion?
Summary and Brief Analysis of New Drugs Approved by NMPA in 2021 PharmaSources/zhulikou431
March 29, 2022
With the revision and promulgation of the Drug Administration Law in 2019, Chinese drug review and approval system has been strengthened and improved.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page